3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
1
Breast
1
Conditions
Breast Neoplasms
285
Lymphoma
201
Lymphoma, Large B-Cell, Diffuse
167
Sarcoma
141
Precursor Cell Lymphoblastic Leukemia-Lymphoma
109
Hodgkin Disease
85
Lymphoma, Non-Hodgkin
78
Burkitt Lymphoma
67
Lymphoma, Follicular
61
Leukemia
58
Ovarian Neoplasms
50
Neoplasms
50
Triple Negative Breast Neoplasms
49
Lymphoma, Mantle-Cell
48
Multiple Myeloma
47
Neuroblastoma
44
Carcinoma, Hepatocellular
44
Neoplasm Metastasis
41
Lymphoma, B-Cell
33
Lymphoma, Large-Cell, Anaplastic
31
Lymphoma, T-Cell, Peripheral
27
Recurrence
26
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
25
Osteosarcoma
25
Liposarcoma
25
Leiomyosarcoma
25
Urinary Bladder Neoplasms
23
Lymphoma, Large-Cell, Immunoblastic
23
Liver Neoplasms
22
Endometrial Neoplasms
21
Interventions
Diathermy
20
Radiotherapy
10
Cisplatin
5
Fluorouracil
4
Drug Therapy
4
Radiation
3
Melphalan
3
Immune Checkpoint Inhibitors
3
Cytoreduction Surgical Procedures
3
Brachytherapy
3
tislelizumab
2
Solutions
2
Immunotherapy
2
Hyperthermia, Induced
2
Hydrogen Peroxide
2
Doxorubicin
2
Conization
2
Capecitabine
2
spartalizumab
1
sodium thiosulfate
1
anlotinib
1
Temozolomide
1
Surgical Procedures, Operative
1
Saline Solution
1
Radiation Dose Hypofractionation
1
Paclitaxel
1
Oxaliplatin
1
Mitomycin
1
Leucovorin
1
Laser Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Hyperthermia
×
Doxorubicin
×
Clear all
NCT06835049
2025-12-30
TNT-HYPE
Swiss Cancer Institute
Phase 2
Recruiting
24 enrolled
NCT01204801
2015-09-24
Medifocus301
Medifocus, Inc.
Phase 3
Unknown
238 enrolled